Literature DB >> 19366980

Nursing Home participation in end-of-life programs: United States, 2004.

Helaine E Resnick1, Gregory L Foster, Susan E Hickman.   

Abstract

The purpose of this report is to define the extent to which US nursing homes (NH) participate in end-of-life programs, using a nationally representative, cross-sectional sample of US NH. Data on EoL programs including Five Wishes, Last Acts, and Physician Orders for Life-Sustaining Treatment (POLST) were collected. In 2004, 17.2% of NH reported participating in 1 or more of these programs, with the largest proportion participating in POLST (13.3%) and smaller proportions in Five Wishes (5.6%) and Last Acts (4.2%). Nursing homes were more likely to participate in EoL programs if they also offered specialty programs and staff training for hospice, end-of-life, pain management, and dementia services. In 2004, fewer than 1 in 5 US NH participated in an EoL program. However, facilities that had EoL programs were more likely to have programs and staff training for services related to EoL care, a finding that suggests a clustering of these programs, services, and training. Provision of appropriate staff training may be a key to expanding EoL program participation in skilled nursing.

Entities:  

Mesh:

Year:  2009        PMID: 19366980     DOI: 10.1177/1049909109333933

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  2 in total

1.  Provider Orders for Life-Sustaining Treatment Implementation and Training in Nursing Facilities in Hawai'i.

Authors:  Pamela Sebastian; Beth Freitas; Daniel Fischberg
Journal:  Hawaii J Med Public Health       Date:  2015-09

2.  Use of the Physician Orders for Life-Sustaining Treatment among California Nursing Home Residents.

Authors:  Lee A Jennings; David Zingmond; Rachel Louie; Chi-Hong Tseng; Judy Thomas; Kate O'Malley; Neil S Wenger
Journal:  J Gen Intern Med       Date:  2016-05-17       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.